Shimada Hideaki

52PUBLICATIONS
64CO-AUTHORS
Social epidemiologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Jun 05, 2026
Outcomes of Gastric Cancer Surgery in Nonagenarians Compared With Patients Aged 85-89 Years: a Multi-Institutional Study.

|Apr 13, 2026
Computational Approach Improves Diagnostic Performance Based on Tumor-Associated Autoantibodies in Esophageal Squamous Cell Carcinoma.

Yosui Nojima, Fumiaki Shiratori, Takashi Suzuki

|Jan 05, 2026
Significance of Serum Tumor Markers in Esophageal and Gastric Cancers: A Systematic Literature Review.

Yasunori Matsumoto, Takeshi Toyozumi, Hideaki Shimada

|Jul 03, 2025
Prognostic significance of six autoantibodies in esophageal squamous cell carcinoma: A prospective multi-institutional study.

Fumiaki Shiratori, Naoto Fujiwara, Yasuaki Nakajima

|Apr 23, 2025
Association between the preoperative Midkine (+)/CEA (+) level and poor prognosis in colorectal cancer patients.

Mitsunori Ushigome, Hideaki Shimada, Masaaki Ito

|Aug 17, 2024
Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases.

Sho Sato, Takashi Suzuki, Takashi Chinen

Pageof 9

Frequent Collaborators

4 joint publications

Makoto Sumazaki

2 joint publications

Takeshi Toyozumi

2 joint publications

Fumiaki Shiratori

2 joint publications

Rei Okada